{"id":"https://openalex.org/W2806909958","doi":"https://doi.org/10.1038/s41598-018-22456-w","title":"Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing","display_name":"Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing","alternate_titles":[],"publication_year":2018,"publication_date":"2018-03-09","ids":{"openalex":"https://openalex.org/W2806909958","doi":"https://doi.org/10.1038/s41598-018-22456-w","mag":"2806909958","pmid":"https://pubmed.ncbi.nlm.nih.gov/29523796","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5844872"},"language":"en","primary_location":{"id":"doi:10.1038/s41598-018-22456-w","doi":"https://doi.org/10.1038/s41598-018-22456-w","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-018-22456-w","pdf_url":"https://www.nature.com/articles/s41598-018-22456-w.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2806909958"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.nature.com/articles/s41598-018-22456-w.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010022627","display_name":"Yan Weng","orcid":"https://orcid.org/0000-0001-6404-5759","observed_orcids":["https://orcid.org/0000-0001-6404-5759"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yan Weng","raw_affiliation_strings":["BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052750879","display_name":"Tetsuya Ishino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tetsuya Ishino","raw_affiliation_strings":["BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084846622","display_name":"Annette Sievers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Annette Sievers","raw_affiliation_strings":["BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059226106","display_name":"Saswata Talukdar","orcid":"https://orcid.org/0000-0003-3042-0025","observed_orcids":["https://orcid.org/0000-0003-3042-0025"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Saswata Talukdar","raw_affiliation_strings":["Internal Medicine, Pfizer Worldwide Research and Development, 1 Portland Street, Cambridge, MA, 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Pfizer Worldwide Research and Development, 1 Portland Street, Cambridge, MA, 02139, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077177263","display_name":"J Chabot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jeffrey R. Chabot","raw_affiliation_strings":["BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102862229","display_name":"Amy Sze Pui Tam","orcid":"https://orcid.org/0009-0004-0832-5093","observed_orcids":["https://orcid.org/0009-0004-0832-5093"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Amy Tam","raw_affiliation_strings":["BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020413888","display_name":"Weili Duan","orcid":"https://orcid.org/0000-0003-1069-140X","observed_orcids":["https://orcid.org/0000-0003-1069-140X"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Weili Duan","raw_affiliation_strings":["BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077611214","display_name":"Kelvin M. Kerns","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kelvin Kerns","raw_affiliation_strings":["BioMedicine Design, Pfizer Worldwide Research and Development, 1 Burtt Road, Andover, MA, 01810, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide Research and Development, 1 Burtt Road, Andover, MA, 01810, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110190010","display_name":"Eric A. Sousa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eric Sousa","raw_affiliation_strings":["BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030754445","display_name":"Tao He","orcid":"https://orcid.org/0000-0002-1533-0761","observed_orcids":["https://orcid.org/0000-0002-1533-0761"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tao He","raw_affiliation_strings":["BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080241478","display_name":"Alison Logan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alison Logan","raw_affiliation_strings":["Internal Medicine, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, CT, 06340, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, CT, 06340, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053722721","display_name":"Darwin Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Darwin Lee","raw_affiliation_strings":["Internal Medicine, Pfizer Worldwide Research and Development, 1 Portland Street, Cambridge, MA, 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Pfizer Worldwide Research and Development, 1 Portland Street, Cambridge, MA, 02139, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100417625","display_name":"Dongmei Li","orcid":"https://orcid.org/0000-0003-1401-5716","observed_orcids":["https://orcid.org/0000-0003-1401-5716","https://orcid.org/0009-0005-3687-2294"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dongmei Li","raw_affiliation_strings":["Internal Medicine, Pfizer Worldwide Research and Development, 1 Portland Street, Cambridge, MA, 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Pfizer Worldwide Research and Development, 1 Portland Street, Cambridge, MA, 02139, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111988046","display_name":"Yingjiang Zhou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yingjiang Zhou","raw_affiliation_strings":["Internal Medicine, Pfizer Worldwide Research and Development, 1 Portland Street, Cambridge, MA, 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Pfizer Worldwide Research and Development, 1 Portland Street, Cambridge, MA, 02139, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004767915","display_name":"Barbara L. Bernardo","orcid":"https://orcid.org/0009-0000-6272-4272","observed_orcids":["https://orcid.org/0009-0000-6272-4272"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Barbara Bernardo","raw_affiliation_strings":["Internal Medicine, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, CT, 06340, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, CT, 06340, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020079496","display_name":"Alison P. Joyce","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alison Joyce","raw_affiliation_strings":["BioMedicine Design, Pfizer Worldwide Research and Development, 1 Burtt Road, Andover, MA, 01810, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide Research and Development, 1 Burtt Road, Andover, MA, 01810, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019351084","display_name":"Mania S. Kavosi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mania Kavosi","raw_affiliation_strings":["BioMedicine Design, Pfizer Worldwide Research and Development, 1 Burtt Road, Andover, MA, 01810, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide Research and Development, 1 Burtt Road, Andover, MA, 01810, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103111596","display_name":"Denise M. O\u2019Hara","orcid":"https://orcid.org/0000-0003-3348-8113","observed_orcids":["https://orcid.org/0000-0003-3348-8113","https://orcid.org/0000-0003-3266-041X"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Denise M. O\u2019Hara","raw_affiliation_strings":["BioMedicine Design, Pfizer Worldwide Research and Development, 1 Burtt Road, Andover, MA, 01810, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide Research and Development, 1 Burtt Road, Andover, MA, 01810, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109293451","display_name":"Tracey H. Clark","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tracey Clark","raw_affiliation_strings":["BioMedicine Design, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, CT, 06340, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, CT, 06340, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103219249","display_name":"Jie Guo","orcid":"https://orcid.org/0000-0003-3605-9891","observed_orcids":["https://orcid.org/0000-0003-3605-9891"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jie Guo","raw_affiliation_strings":["BioMedicine Design, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, CA, 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, CA, 92121, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021642714","display_name":"Craig Giragossian","orcid":"https://orcid.org/0000-0002-6470-8628","observed_orcids":["https://orcid.org/0000-0002-6470-8628"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Craig Giragossian","raw_affiliation_strings":["BioMedicine Design, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, CT, 06340, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, CT, 06340, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mark Stahl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark Stahl","raw_affiliation_strings":["BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037077908","display_name":"Roberto A. Calle","orcid":"https://orcid.org/0000-0001-6577-5657","observed_orcids":["https://orcid.org/0000-0001-6577-5657"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Roberto A. Calle","raw_affiliation_strings":["Internal Medicine, Pfizer Worldwide Research and Development, 1 Portland Street, Cambridge, MA, 02139, USA"],"raw_orcid":"https://orcid.org/0000-0001-6577-5657","affiliations":[{"raw_affiliation_string":"Internal Medicine, Pfizer Worldwide Research and Development, 1 Portland Street, Cambridge, MA, 02139, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113606329","display_name":"Ron Kriz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ron Kriz","raw_affiliation_strings":["BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077358980","display_name":"Will Somers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Will Somers","raw_affiliation_strings":["BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062835519","display_name":"Laura Lin","orcid":"https://orcid.org/0000-0003-1619-7437","observed_orcids":["https://orcid.org/0000-0003-1619-7437"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Laura Lin","raw_affiliation_strings":["BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA. laura.lin@pfizer.com","BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA. laura.lin@pfizer.com","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA, 02139, USA","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5062835519"],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":{"value":2690,"currency":"USD","value_usd":2690},"apc_paid":{"value":2690,"currency":"USD","value_usd":2690},"fwci":0.9041,"has_fulltext":true,"cited_by_count":34,"citation_normalized_percentile":{"value":0.69923699,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":98},"biblio":{"volume":"8","issue":"1","first_page":"4241","last_page":"4241"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fgf21-analogues","display_name":"FGF21 analogues","score":0.8960000276565552},{"id":"https://openalex.org/keywords/glycoengineering","display_name":"glycoengineering","score":0.7820000052452087},{"id":"https://openalex.org/keywords/fc-fusion","display_name":"Fc fusion","score":0.8799999952316284},{"id":"https://openalex.org/keywords/protease-resistance","display_name":"protease resistance","score":0.7950000166893005},{"id":"https://openalex.org/keywords/protein-solubility","display_name":"protein solubility","score":0.7260000109672546},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7450000047683716},{"id":"https://openalex.org/keywords/subcutaneous-dosing","display_name":"subcutaneous dosing","score":0.8299999833106995},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.656000018119812},{"id":"https://openalex.org/keywords/glucose-tolerance","display_name":"glucose tolerance","score":0.8920000195503235},{"id":"https://openalex.org/keywords/metabolic-disorders","display_name":"metabolic disorders","score":0.6320000290870667},{"id":"https://openalex.org/keywords/ob-ob-mice","display_name":"ob/ob mice","score":0.6880000233650208},{"id":"https://openalex.org/keywords/diet-induced-obesity","display_name":"diet-induced obesity","score":0.6840000152587891},{"id":"https://openalex.org/keywords/cynomolgus-monkeys","display_name":"Macaca fascicularis","score":0.7950000166893005}],"concepts":[{"id":"https://openalex.org/C106646824","wikidata":"https://www.wikidata.org/wiki/Q5425475","display_name":"FGF21","level":4,"score":0.6755213141441345},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6051299571990967},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5799956917762756},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5632754564285278},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.444505900144577},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.4428960382938385},{"id":"https://openalex.org/C175656101","wikidata":"https://www.wikidata.org/wiki/Q56646","display_name":"Chinese hamster ovary cell","level":3,"score":0.43240976333618164},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34149134159088135},{"id":"https://openalex.org/C74373430","wikidata":"https://www.wikidata.org/wiki/Q24727126","display_name":"Fibroblast growth factor","level":3,"score":0.1450764536857605},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.10046452283859253}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003412","descriptor_name":"Cricetulus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005346","descriptor_name":"Fibroblast Growth Factors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005346","descriptor_name":"Fibroblast Growth Factors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D005346","descriptor_name":"Fibroblast Growth Factors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006031","descriptor_name":"Glycosylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006224","descriptor_name":"Cricetinae","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008252","descriptor_name":"Macaca fascicularis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016466","descriptor_name":"CHO Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055550","descriptor_name":"Protein Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057809","descriptor_name":"HEK293 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059748","descriptor_name":"Proteolysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1038/s41598-018-22456-w","doi":"https://doi.org/10.1038/s41598-018-22456-w","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-018-22456-w","pdf_url":"https://www.nature.com/articles/s41598-018-22456-w.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5844872","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5844872/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sci Rep","raw_type":"Text"},{"id":"pmid:29523796","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29523796","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific reports","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:0d0c03fce8a64b669901e0366635b527","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/0d0c03fce8a64b669901e0366635b527","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Scientific Reports, Vol 8, Iss 1, Pp 1-15 (2018)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1038/s41598-018-22456-w","doi":"https://doi.org/10.1038/s41598-018-22456-w","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-018-22456-w","pdf_url":"https://www.nature.com/articles/s41598-018-22456-w.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2806909958.pdf","grobid_xml":"https://content.openalex.org/works/W2806909958.grobid-xml"},"referenced_works_count":58,"referenced_works":["https://openalex.org/W1522113235","https://openalex.org/W1555185942","https://openalex.org/W1947454816","https://openalex.org/W1964063591","https://openalex.org/W1969482494","https://openalex.org/W1970362460","https://openalex.org/W1972717747","https://openalex.org/W1972879829","https://openalex.org/W1976394313","https://openalex.org/W1984370122","https://openalex.org/W1989618690","https://openalex.org/W1997578973","https://openalex.org/W2000368348","https://openalex.org/W2000665430","https://openalex.org/W2003495422","https://openalex.org/W2012972704","https://openalex.org/W2026300445","https://openalex.org/W2027239974","https://openalex.org/W2029880965","https://openalex.org/W2038373191","https://openalex.org/W2038863889","https://openalex.org/W2039756071","https://openalex.org/W2048411348","https://openalex.org/W2062842771","https://openalex.org/W2064125892","https://openalex.org/W2067933166","https://openalex.org/W2068623317","https://openalex.org/W2074337024","https://openalex.org/W2075068090","https://openalex.org/W2076037986","https://openalex.org/W2080776158","https://openalex.org/W2081787960","https://openalex.org/W2083299402","https://openalex.org/W2086820922","https://openalex.org/W2102454657","https://openalex.org/W2103475664","https://openalex.org/W2111653877","https://openalex.org/W2113785887","https://openalex.org/W2114650931","https://openalex.org/W2119331212","https://openalex.org/W2119351413","https://openalex.org/W2135819931","https://openalex.org/W2140433681","https://openalex.org/W2144461742","https://openalex.org/W2145044799","https://openalex.org/W2145908121","https://openalex.org/W2155010729","https://openalex.org/W2156319327","https://openalex.org/W2168118376","https://openalex.org/W2169177790","https://openalex.org/W2179347489","https://openalex.org/W2269548696","https://openalex.org/W2290076360","https://openalex.org/W2294754341","https://openalex.org/W2334946637","https://openalex.org/W2418734587","https://openalex.org/W2611434197","https://openalex.org/W4213063635"],"related_works":["https://openalex.org/W3107896769","https://openalex.org/W2145044799","https://openalex.org/W2003495422","https://openalex.org/W2029880965","https://openalex.org/W2611434197","https://openalex.org/W4400678379","https://openalex.org/W3199378119","https://openalex.org/W4408530077"],"abstract_inverted_index":{"Pharmacological":[0],"administration":[1],"of":[2,32,37,42,119,178,195],"FGF21":[3,75,167],"analogues":[4],"has":[5],"shown":[6],"robust":[7,129],"body":[8,151],"weight":[9,152],"reduction":[10],"and":[11,20,30,49,58,84,104,134,159,175],"lipid":[12],"profile":[13,86,177],"improvement":[14,130],"in":[15,66,113,131,144,154],"both":[16],"dysmetabolic":[17],"animal":[18],"models":[19],"metabolic":[21,196],"disease":[22],"patients.":[23],"Here":[24],"we":[25,71],"report":[26],"the":[27,123,135,172],"design,":[28],"optimization,":[29],"characterization":[31],"a":[33,40,59,73,98],"long":[34,105],"acting":[35],"glyco-variant":[36],"FGF21.":[38],"Using":[39],"combination":[41],"N-glycan":[43],"engineering":[44],"for":[45,54,63,110,183,192],"enhanced":[46],"protease":[47],"resistance":[48],"improved":[50,82],"solubility,":[51],"Fc":[52],"fusion":[53],"further":[55],"half-life":[56,107],"extension,":[57],"single":[60,141],"point":[61],"mutation":[62],"improving":[64],"manufacturability":[65],"Chinese":[67],"Hamster":[68],"Ovary":[69],"cells,":[70],"created":[72],"novel":[74],"analogue,":[76],"Fc-FGF21[R19V][N171]":[77],"or":[78],"PF-06645849,":[79],"with":[80,90],"substantially":[81],"solubility":[83],"stability":[85],"that":[87,116],"is":[88],"compatible":[89],"subcutaneous":[91],"(SC)":[92],"administration.":[93],"In":[94,170],"particular,":[95],"it":[96],"showed":[97],"low":[99],"systemic":[100],"clearance":[101],"(0.243":[102],"mL/hr/kg)":[103],"terminal":[106],"(~200":[108],"hours":[109],"intact":[111],"protein)":[112],"cynomolgus":[114],"monkeys":[115],"approaches":[117],"those":[118],"monoclonal":[120],"antibodies.":[121],"Furthermore,":[122],"superior":[124],"PK":[125],"properties":[126],"translated":[127],"into":[128],"glucose":[132],"tolerance":[133],"effects":[136],"lasted":[137],"14":[138],"days":[139],"post":[140],"SC":[142,162,189],"dose":[143],"ob/ob":[145],"mice.":[146],"PF-06645849":[147,179],"also":[148],"caused":[149],"greater":[150],"loss":[153],"DIO":[155],"mice":[156],"at":[157],"lower":[158],"less":[160],"frequent":[161],"doses,":[163],"compared":[164],"to":[165,187],"previous":[166],"analogue":[168],"PF-05231023.":[169],"summary,":[171],"overall":[173],"PK/PD":[174],"pharmaceutical":[176],"offers":[180],"great":[181],"potential":[182],"development":[184],"as":[185],"weekly":[186],"twice-monthly":[188],"administered":[190],"therapeutic":[191],"chronic":[193],"treatment":[194],"diseases.":[197]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2806909958","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2018-06-13T00:00:00"}
